Asia Pacific Laparoscopic Power Morcellators Market By Application (Hysterectomy, Myomectomy and Other Applications), By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

The Asia Pacific Laparoscopic Power Morcellators Market is expected to witness market growth of 9.9% CAGR during the forecast period (2021-2027).

The increasing preference for minimally invasive gynecological procedures and the adoption of technological advancements in surgical devices are the main factors anticipated to drive the market. Power morcellators are devices that are less invasive. Thus, they are used in surgical procedures like fibroid removal and hysterectomy that involves cutting tissues into smaller pieces.

The market for laparoscopic power morcellators in the Asia Pacific is witnessing considerable growth in recent years. It is due to the increasing number of myomectomy and hysterectomy surgeries in emerging nations like India, China, and others. The factors include the increasing patient pool who is suffering from health disorders like endometritis, uterine fibroids, abnormal bleeding, and others. With growing disposable income, there is a rise in expenditure on medical facilities, which in turn have a positive impact on the demand for laparoscopic power morcellators in the healthcare sector in this region.

Also, the growing awareness about women’s health problems including uterine fibroids and their diagnostic approaches in developing economies are likely to create profitable growth opportunities in the Asia Pacific market during the forecast period. In addition, healthcare infrastructure is also improving in developing countries along with the adoption of technologically advanced surgical tools. All these factors are expected to drive the growth of the laparoscopic power morcellators market in the coming years.

The Hysterectomy market dominated the Malaysia Laparoscopic Power Morcellators Market by Application in 2020, thereby, achieving a market value of $1,068.5 Thousands by 2027. The Myomectomy market is expected to witness a CAGR of 10.7% during (2021 - 2027).

Based on Application, the market is segmented into Hysterectomy, Myomectomy and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Karl Storz SE & Co. KG, Cook Medical, Inc. (Cook Group), Olympus Corporation, Johnson and Johnson, Lina Medical, Nouvag AG, Rudolf Medical GmbH, OWA- Electronic GmbH & Co. KG, and Richard Wolf GmbH.

Scope of the Study

Market Segments covered in the Report:

By Application

• Hysterectomy
• Myomectomy
• Other Applications

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Companies Profiled

• Medtronic PLC
• Karl Storz SE & Co. KG
• Cook Medical, Inc. (Cook Group)
• Olympus Corporation
• Johnson and Johnson
• Lina Medical
• Nouvag AG
• Rudolf Medical GmbH
• OWA- Electronic GmbH & Co. KG
• Richard Wolf GmbH

Unique Offerings from the Publisher

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free